Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PPOX | P50336 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carfentrazone-Ethyl SCHEMBL7579165 | 0.92 | TP53 (0.39) | TP53THRBTDP1ALDH1A1CYP3A4 | |
| Carfentrazone-Ethyl SCHEMBL7584978 | 0.91 | TP53 (0.49) | TP53TDP1ALDH1A1CYP3A4MEN1 | |
| Carfentrazone-Ethyl SCHEMBL7581322 | 0.91 | TP53 (0.38) | TP53THRBDHODH | |
| Carfentrazone-Ethyl SCHEMBL7588086 | 0.90 | TP53 (0.37) | TP53THRBDHODH | |
| Carfentrazone-Ethyl SCHEMBL7582032 | 0.90 | NR1I2 (0.49) | TDP1MEN1KMT2ANR1I2DHODH | |
| Carfentrazone-Ethyl SCHEMBL7581357 | 0.88 | TP53 (0.36) | TP53DHODH | |
| Carfentrazone-Ethyl SCHEMBL7580784 | 0.88 | DHODH (0.37) | DHODH | |
| Carfentrazone-Ethyl SCHEMBL7579519 | 0.87 | TP53 (0.35) | TP53THRBMEN1KMT2A | |
| Carfentrazone-Ethyl SCHEMBL7585688 | 0.86 | MAPT (0.40) | THRBALDH1A1MEN1KMT2ADHODH | |
| Carfentrazone-Ethyl SCHEMBL7587221 | 0.86 | TP53 (0.34) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | TP53 4303/4885THRB 2326/4885TDP1 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.